HANGZHOU, CHINA - JANUARY 27, 2025 - A Illustration photo shows DeepSeek and Nvidia LOGO in Hangzhou ... See: What’s Happening With Tempus AI (TEM) Stock? This cost efficiency is reflected ...
This article summarizes the most significant insider buying and selling activities reported on Friday for US-listed companies ...
Multiple executives at Tempus AI Inc. executed significant share sales totaling $20.3 million between Feb. 4-7, according to ...
Beyond Stargate's big players, a growing number of innovators have been revolutionizing healthcare by making recent ...
TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...
In a regulatory filing, Tempus AI (TEM) disclosed that COO Ryan Fukushima sold 20,000 shares of the company’s stock. The stock was sold at an ...
In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as ...
Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared to its daily average volume of about 5.67 million. All thanks to three ...
Tempus AI (TEM) is soaring 13% today after investment bank TD Cowen reinstated coverage of the shares with a Buy rating. TEM provides next generation sequencing diagnostics, polymerase chain ...
Tempus AI’s moat on its healthcare diagnostics platform is being built around three main product lines, although revenue is mainly being driven by Genomics and Data. Diagnostic testing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results